SEC Accuses FDA Chemist Of Insider Trading
Regulators?expanded charges against a chemist?accused of using confidential FDA information on pending drug approvals to profit from trades.

Finasteride And Dutasteride Raise Risk Of High-Grade Prostate Cancer, FDA Informs
Although finasteride and dutasteride lower overall risk of developing prostate cancer, they raise the chances of developing high-grade prostate cancer, a more serious form of the disease, the FDA (Food and Drug Administration) has announced. The Agency adds that the risk is low; but doctors need to be aware of this. The FDA announced that all 5-alpha reductase inhibitor (5-ARI) medications will ...